# The Effects of Gut Microbiota, Plasma Metabolites, Immune Cells, Blood Cells and Cytokines on Schizophrenia: A Bidirectional Two-Sample Mendelian Randomisation Study

**Authors:** Kaihong Zhang, Wen Sun, Qingxiang Meng, Gaowei Liu, Xinyuan Hu, Sufang Qi, Xi Liu, Wei Wang, Junmei Wei, Jiawei Jin, Cuicui Zhang, Yu Cao

PMC · DOI: 10.62641/aep.v54i1.2014 · Actas Españolas de Psiquiatría · 2026-02-15

## TL;DR

This study explores how gut microbiota, metabolites, immune cells, and other factors are linked to schizophrenia using genetic data, revealing potential new pathways for understanding and treating the disorder.

## Contribution

A bidirectional two-sample Mendelian randomisation study identifies causal links and mediators between the gut-metabolite-immune network and schizophrenia.

## Key findings

- 62 traits from gut microbiota, metabolites, immune cells, and cytokines showed causal connections to schizophrenia.
- Nine pathways were identified by which gut microbiota influences schizophrenia via plasma metabolites and immune cells.
- The Firmicutes phylum of gut microbiota was most significantly associated with schizophrenia.

## Abstract

The aberrant traits of the gut–metabolite–immune network in schizophrenia imply a crucial interrelationship among them. The exploration of the association between the gut–metabolite–immune network and schizophrenia will create novel opportunities for future studies on the disorder.

This study utilised the Mendelian randomisation (MR) method to examine the causal relationships among gut microbiota, plasma metabolites, immune cells, blood cells, cytokines and schizophrenia. Additionally, mediation analysis was performed to identify and verify potential mediators involved in the pathway linking gut microbiota to schizophrenia.

A total of 62 traits with causal connections to schizophrenia were identified from the gut microbiota, plasma metabolites, immune cells, blood cells and cytokines (11 traits from the gut microbiota [odds ratio (OR) = 0.683–2.104, p = 0.005–0.047], 35 traits from plasma metabolites [OR = 0.596–1.597, p = 0.005–0.049], 14 traits from immune cells [OR = 0.813–1.105, p = 0.005–0.049], 1 trait from blood cells [OR = 1.112, p = 0.038] and 1 trait from cytokines [OR = 0.864, p = 0.041]). Among them, 30 traits were classified as risk factors for schizophrenia. Additionally, we determined nine pathways by which gut microbiota influences schizophrenia (via 7 plasma metabolites and 2 immune cells). Moreover, in our MR analyses, several sensitivity analyses were employed to eliminate heterogeneity and horizontal pleiotropy, ensuring reliable MR results. Meanwhile, the outcomes of various analyses revealed that the gut microbiota most significantly associated with schizophrenia belonged to the Firmicutes phylum.

These discoveries not only deepen our understanding of the pathogenic mechanism of schizophrenia but also offer significant impetus for the development of future diagnostic studies and therapeutic strategies.

## Linked entities

- **Diseases:** schizophrenia (MONDO:0005090)

## Full-text entities

- **Genes:** CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL2RA (interleukin 2 receptor subunit alpha) [NCBI Gene 3559] {aka CD25, IDDM10, IL2R, IMD41, TCGFR, p55}, HCAR2 (hydroxycarboxylic acid receptor 2) [NCBI Gene 338442] {aka GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG}, HOPX (HOP homeobox) [NCBI Gene 84525] {aka CAMEO, HOD, HOP, LAGY, NECC1, OB1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}
- **Diseases:** brain diseases (MESH:D001927), cognitive dysfunction (MESH:D003072), breast cancer (MESH:D001943), mental disorders (MESH:D001523), Alzheimer's  disease (MESH:D000544), SCZ (MESH:D012559), neuroinflammatory (MESH:D000090862), inflammation (MESH:D007249), granulocytopenia (MESH:D000380), neurological disorder (MESH:D009461)
- **Chemicals:** amino acid (MESH:D000596), carbohydrate (MESH:D002241), N-acetylserine (MESH:C012162), GABA (-), -aminobutyric acid (MESH:D000613), L-carnitine (MESH:D002331), amisulpride (MESH:D000077582), tryptophan (MESH:D014364), SCFA (MESH:D005232), lipid (MESH:D008055), N-Acetylalanine (MESH:C010530), glutamate (MESH:D018698), kynurenine (MESH:D007737)
- **Species:** Homo sapiens (human, species) [taxon 9606], Bacilli (class) [taxon 91061], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Clostridia (class) [taxon 186801], Pseudomonadota (proteobacteria, phylum) [taxon 1224]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946721/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12946721/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946721/full.md

---
Source: https://tomesphere.com/paper/PMC12946721